B01 - Notice of Intent to Award a Sole Source.docx

HT94257302025

NOTICE OF INTENT TO SOLE SOURCE:

This notice announces the intent by the U.S. Army Medical Research Acquisition Activity (USAMRAA) in support of the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) to award a firm-fixed priced, sole source, contract to CN Bio Innovations Limited, 332 Cambridge Science Park Cambridge, Cambridgeshire CB4 0WN UK for one (1) PhysioMimix Organ-on-a-Chip (OOC) Multi-Organ Standard System (PMX-M1-SYS) and one (1) PhysioMimix Organ-on-a-Chip (OOC) Multi-Organ Full System. The Contractor will provide onsite installation and onsite training for USAMRIID personnel. The systems shall be able to support single and multi-organ on a chip systems. Market research examined if there are other sources capable of providing the required PhysioMimix OOC Multi-Organ Standard System. It was determined that although there are multiple vendors in the market capable of providing similar equipment, the similar equipment does not meet all Government Minimum Essential Characteristics (MECs). Further, CN Bio Innovations does not have any authorized resellers. Therefore, CN Bio Innovations is determined to be the only vendor capable of providing a system that meets all requirements of the Government. As a result, the Government intends to make an award to CN Bio Innovations.

The North American Industry Classification System (NAICS) for this requirement is 334516 Analytical Lab Instrument Manufacturing

This announcement fulfills the synopsis requirements under FAR 5.201. This Special Notice of Intent is not a request for competitive quotes and no solicitation document exists for this requirement; however, if a vendor challenges the basis for this requirement, please submit a capability statement that includes sufficient detail and with convincing evidence that clearly demonstrates the capability to provide the equipment identified within this notice.

A determination by the Government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government. A request for documentation or additional information or submissions that only ask questions will not be considered as an affirmative response. A determination by the Government not to compete based on responses to this notice is solely within the discretion of the Government. Information received in response to this notice will be considered solely for the purpose of determining whether a competitive procurement or a sole source procurement is in the best interest of the Government.

All questions and responses concerning this notice shall be emailed to Matthew Gembe via email at matthew.w.gembe.civ@health.mil.

Capability statements are due, in writing, to the email address listed above no later than 1500 Eastern Time, 14 April 2025. Capability statements shall be submitted via email ONLY as Microsoft Word or Adobe PDF attachment. No phone calls will be accepted.